Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Precision Medicine
MedTech
FDA looks to bypass cancer drugs' companion diagnostics: Pazdur
The FDA is working on a pilot program that would allow doctors to choose a cancer drug's tests rather than sticking to specific companion diagnostics.
Angus Liu
Nov 18, 2022 9:17am
After $500M unveiling, Neumora returns with sophomore financing
Oct 11, 2022 6:30am
Versant-founded Nested flies off with $90M series A
Oct 6, 2022 8:00am
Machine learning to hone precision meds for cancer backup genes
Sep 29, 2022 3:30pm
IDRx nabs $122M to address precision medicine 'whack-a-mole'
Aug 2, 2022 6:30am
Boehringer rounds up allies to build €40M anti-superbug startup
Jul 6, 2022 6:01am
